Halberd Corp. (HALB)
0.0013
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Halberd Max Drawdown (5Y) : 98.63% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.63% |
| August 31, 2026 | 98.63% |
| July 31, 2026 | 98.63% |
| June 30, 2026 | 98.52% |
| May 31, 2026 | 98.52% |
| April 30, 2026 | 98.52% |
| March 31, 2026 | 98.52% |
| February 28, 2026 | 98.52% |
| January 31, 2026 | 98.52% |
| December 31, 2025 | 98.52% |
| November 30, 2025 | 98.34% |
| October 31, 2025 | 97.91% |
| September 30, 2025 | 97.91% |
| August 31, 2025 | 97.91% |
| July 31, 2025 | 97.91% |
| June 30, 2025 | 97.91% |
| May 31, 2025 | 97.91% |
| April 30, 2025 | 97.54% |
| March 31, 2025 | 97.41% |
| February 28, 2025 | 97.29% |
| January 31, 2025 | 96.31% |
| December 31, 2024 | 96.31% |
| November 30, 2024 | 96.31% |
| October 31, 2024 | 95.79% |
| September 30, 2024 | 95.79% |
| Date | Value |
|---|---|
| August 31, 2024 | 95.79% |
| July 31, 2024 | 95.79% |
| June 30, 2024 | 95.79% |
| May 31, 2024 | 95.79% |
| April 30, 2024 | 95.79% |
| March 31, 2024 | 95.79% |
| February 29, 2024 | 95.79% |
| January 31, 2024 | 95.79% |
| December 31, 2023 | 95.79% |
| November 30, 2023 | 95.44% |
| October 31, 2023 | 95.44% |
| September 30, 2023 | 95.44% |
| August 31, 2023 | 95.79% |
| July 31, 2023 | 96.32% |
| June 30, 2023 | 96.84% |
| May 31, 2023 | 96.96% |
| April 30, 2023 | 96.96% |
| March 31, 2023 | 97.18% |
| February 28, 2023 | 98.21% |
| January 31, 2023 | 98.44% |
| December 31, 2022 | 98.44% |
| November 30, 2022 | 98.44% |
| October 31, 2022 | 98.56% |
| September 30, 2022 | 99.30% |
| August 31, 2022 | 99.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| Altimmune, Inc. | 93.57% |
| AnaptysBio, Inc. | 85.45% |
| Aligos Therapeutics, Inc. | 99.54% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -54.31 |
| Beta (5Y) | 0.1006 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.99% |
| Historical Sharpe Ratio (5Y) | -0.6664 |
| Historical Sortino (5Y) | -1.584 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.30% |